Cellipont Bioservices is a cell therapy CDMO with more than 15 years’ experience in the development and small-to-large batch manufacturing of cell therapies. With more than 18,000 tissue samples and 1,800+ primary cell cultures, our expertise runs deep.

Cellipont sees itself as a direct extension of our clients’ organizations. We take personal ownership for the success of your programs, and we work tirelessly and with full transparency to ensure your objectives are met.

Cellipont Bioservices has been advancing cell therapy since the industry’s early days. We’ve earned a reputation as a “go-to” partner for culturing difficult cell types and technology developers often turn to us to put their promising new tools to the test.

We are inspired every day by the breakthrough science of our innovator clients. But our true inspiration is the hopeful patient waiting for a life-saving treatment. We know our work today means someone might see another tomorrow.